Prostate Cancer
📧 Sign up to get email alerts when something new happens for Prostate Cancer.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2024-01-17Clinical Trial Update: Nivolumab With or Without Ipilimumab in Advanced Metastatic Cancer [Phase 2]
Phase 2 trial assessing nivolumab with or without ipilimumab in advanced metastatic cancer, completed with results posted in 2024.
-
CLINICAL_TRIALS trial_result · 2024-01-16Clinical Trial Update: TAVT-45 (Abiraterone Acetate) Granules in Patients With Prostate Cancer [Phase 3]
Phase 3 trial update for TAVT-45 (Abiraterone Acetate) granules in metastatic prostate cancer patients has completed with results posted.
-
CLINICAL_TRIALS trial_result · 2024-01-12Clinical Trial Update: Study to Compare the Effects of Repeated Doses of an Investigational New Drug and a Placebo on Appetite in Advanced Cancer and Anorexia [Phase 1]
Phase 1 study comparing repeated doses of an investigational drug versus placebo to assess effects on appetite in advanced cancer and anorex…
-
CLINICAL_TRIALS trial_result · 2024-01-11Clinical Trial Update: 68Ga PSMA 11 PET/MRI and 68Ga RM2 PET/MRI for Biopsy Guidance in Patients With Suspected Prostate Cancer [Phase 2]
Phase 2 trial update evaluating 68Ga PSMA-11 PET/MRI and 68Ga RM2 PET/MRI for biopsy guidance in suspected prostate cancer.
-
CLINICAL_TRIALS trial_result · 2024-01-11Clinical Trial Update: GTN Therapy on Biomarkers of Immune Escape in Men With Biochemical Recurrence of Prostate Cancer After Primary Therapy [Phase 2]
Phase 2 clinical trial update evaluating GTN therapy effects on biomarkers of immune escape in men with biochemical recurrence of prostate c…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2024-01-05Clinical Trial Update: Patient Preference of Apalutamide Versus Enzalutamide in Patients With Recurrent or Metastatic Hormone-Sensitive Prostate Cancer [Phase 3]
Phase 3 trial comparing patient preference between apalutamide and enzalutamide in recurrent or metastatic hormone-sensitive prostate cancer…
-
CLINICAL_TRIALS trial_result · 2024-01-05Clinical Trial Update: ARFI Imaging for Targeted Prostate Biopsy [NA]
Duke University-sponsored trial evaluating ARFI imaging for targeted prostate biopsy was terminated; results have been posted.
-
CLINICAL_TRIALS trial_result · 2024-01-02Clinical Trial Update: Study of Histrelin Subdermal Implant in Patients With Prostate Cancer [Phase 3]
Phase 3 clinical trial investigating the histrelin subdermal implant in patients with prostate cancer has been completed.
-
CLINICAL_TRIALS trial_result · 2024-01-02Clinical Trial Update: Study to Evaluate Efficacy and Safety of Histrelin Subdermal Implant in Men With Advanced Prostate Cancer [Phase 3]
Phase 3 clinical trial evaluating histrelin subdermal implant for advanced prostate cancer has completed.
-
CLINICAL_TRIALS trial_result · 2024-01-02Clinical Trial Update: Prothrombin Complex Concentrate vs Fresh Frozen Plasma in Goal-directed Bleeding Management in Non-cardiac Surgery [Phase 4]
Phase 4 clinical trial comparing Prothrombin Complex Concentrate with Fresh Frozen Plasma for goal-directed bleeding management in non-cardi…
-
CLINICAL_TRIALS trial_result · 2023-12-26Clinical Trial Update: Intermittent Darolutamide Treatment in the Triple Therapy of mHSPC [Phase 3]
Phase 3 clinical trial evaluating intermittent darolutamide treatment as part of triple therapy for metastatic hormone-sensitive prostate ca…
-
CLINICAL_TRIALS trial_result · 2023-12-20Clinical Trial Update: Study of Pembrolizumab (MK-3475) Plus Enzalutamide Versus Placebo Plus Enzalutamide in Participants With Metastatic Castration-resistant Prostate Cancer (mCRPC) (MK-3475-641/KEYNOTE-641) [Phase 3]
Phase 3 trial evaluating pembrolizumab plus enzalutamide versus placebo plus enzalutamide in metastatic castration-resistant prostate cancer…
-
CLINICAL_TRIALS trial_result · 2023-12-18Clinical Trial Update: A Parallel Arm Phase 1b/2a Study of DKN-01 as Monotherapy or in Combination With Docetaxel for the Treatment of Advanced Prostate Cancer With Elevated DKK1 [Phase 1, Phase 2]
Phase 1b/2a trial of DKN-01 as monotherapy or with docetaxel in advanced prostate cancer with elevated DKK1 was terminated; results posted.
-
CLINICAL_TRIALS trial_result · 2023-12-15Clinical Trial Update: EVOLUTION: 177Lu-PSMA Therapy Versus 177Lu-PSMA in Combination With Ipilimumab and Nivolumab for Men With mCRPC [Phase 2]
Phase 2 clinical trial update comparing 177Lu-PSMA therapy alone versus 177Lu-PSMA with ipilimumab and nivolumab in men with metastatic cast…
-
CLINICAL_TRIALS trial_result · 2023-12-13Clinical Trial Update: Long-term Better Than Short-term ADT With Salvage RT [Phase 2, Phase 3]
A clinical trial update investigating long-term androgen deprivation therapy (ADT) with salvage radiotherapy for prostate cancer, currently …
-
CLINICAL_TRIALS trial_result · 2023-12-08Clinical Trial Update: Fluzoparib and Abiraterone in the preSurgery Treatment of Prostate Cancer: FAST Trial [Phase 2]
Phase 2 FAST trial evaluating fluzoparib and abiraterone as pre-surgery treatment for high-risk prostate cancer in a neoadjuvant setting.
-
CLINICAL_TRIALS trial_result · 2023-12-07Clinical Trial Update: PET Imaging in MCI Following ADT for PCa
A completed clinical trial evaluating PET imaging in individuals with mild cognitive impairment following androgen deprivation therapy for p…
-
CLINICAL_TRIALS trial_result · 2023-12-06Clinical Trial Update: pTVG-HP and Nivolumab in Patients With Non-Metastatic PSA-Recurrent Prostate Cancer [Phase 2]
A Phase 2 clinical trial update evaluating pTVG-HP in combination with nivolumab for non-metastatic PSA-recurrent prostate cancer; results h…
-
CLINICAL_TRIALS trial_result · 2023-12-01Clinical Trial Update: Hypofractionated Focal Lesion Ablative Microboost in prostatE Cancer 2.0 [Phase 2]
Phase 2 trial update for hypofractionated focal lesion ablative microboost in prostate cancer (prostate adenocarcinoma).
-
CLINICAL_TRIALS trial_result · 2023-11-29Clinical Trial Update: Enzalutamide and Indomethacin in Treating Patients With Recurrent or Metastatic Hormone-Resistant Prostate Cancer [Phase 1, Phase 2]
A Phase 1/2 clinical trial investigating enzalutamide in combination with indomethacin for recurrent or metastatic hormone-resistant prostat…
-
CLINICAL_TRIALS trial_result · 2023-11-27Clinical Trial Update: 68Ga-PSMA PET/CT in Prostate Cancer [Phase 3]
Phase 3 trial update on 68Ga-PSMA PET/CT in prostate cancer has completed.
-
CLINICAL_TRIALS trial_result · 2023-11-27Clinical Trial Update: Prostate Cancer Patient Management With 18F-DCFPyL PET/CT [Phase 2, Phase 3]
Clinical trial update for prostate cancer exploring 18F-DCFPyL PET/CT imaging across Phase 2 and Phase 3.
-
CLINICAL_TRIALS trial_result · 2023-11-24Clinical Trial Update: Effects of a Genistein Concentrated Polysaccharide (GCP) for Prostate Cancer on Active Surveillance. [Phase 2, Phase 3]
Clinical trial update on genistein concentrated polysaccharide (GCP) for prostate cancer on active surveillance; completed Phase 2/Phase 3 t…
-
CLINICAL_TRIALS trial_result · 2023-11-22Clinical Trial Update: Phase I/II Study of Hydroxychloroquine With Itraconazole With Biochemically Recurrent Prostate Cancer [Phase 1, Phase 2]
A phase I/II clinical trial evaluating hydroxychloroquine in combination with itraconazole for biochemically recurrent prostate cancer has c…
-
CLINICAL_TRIALS trial_result · 2023-11-18Clinical Trial Update: A Study of Niraparib Combination Therapies for the Treatment of Metastatic Castration-Resistant Prostate Cancer [Phase 2]
Phase 2 trial evaluating niraparib in combination therapies for metastatic castration-resistant prostate cancer; the study is active/not rec…